NCT01454596 2019-08-21CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIIINational Institutes of Health Clinical Center (CC)Phase 1/2 Completed18 enrolled 25 charts